Literature DB >> 31291781

Detection of Inflammatory Aortopathies Using Multimodality Imaging.

John P Bois1, Vidhu Anand1, Nandan S Anavekar1.   

Abstract

Diagnosis of the inflammatory aortopathies and importantly, their distinction in the later stages of disease from genetically mediated or acquired (degenerative) aortopathy remains a challenging clinical problem. Historically, the diagnosis of inflammatory aortopathy has required tissue sampling and pathological assessment. Although histological diagnosis remains an important diagnostic criterion, the ability to obtain sufficient tissue samples is problematic and requires invasive approaches that pose important risk. Continuing refinement in the capabilities of multimodality imaging, including ultrasound, computed tomography, magnetic resonance imaging, and positron emission tomography provides important insights into the broad spectrum of disease which comprise the inflammatory aortopathies. This review examines the current and emerging role of multimodality imaging in the evaluation of aortitis.

Entities:  

Keywords:  Takayasu arteritis; angiography; echocardiography; magnetic resonance imaging; positron emission tomography

Mesh:

Year:  2019        PMID: 31291781     DOI: 10.1161/CIRCIMAGING.118.008471

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  3 in total

Review 1.  Role of Cardiovascular Magnetic Resonance to Assess Cardiovascular Inflammation.

Authors:  Domenico Filomena; Tom Dresselaers; Jan Bogaert
Journal:  Front Cardiovasc Med       Date:  2022-07-06

2.  Hidden in Plain Sight: Discovering Giant Cell Aortopathy During Surgical Mitral Valve Repair.

Authors:  Najah A Khan; Daniel Li; Emily Newstrom; Roberto Barrios; Mohammed Attar
Journal:  JACC Case Rep       Date:  2022-05-04

3.  Imaging characteristics and diagnostic accuracy of FDG-PET/CT, contrast enhanced CT and combined imaging in patients with suspected mycotic or inflammatory abdominal aortic aneurysms.

Authors:  Lars Husmann; Martin W Huellner; Hannes Gruenig; Bruno Ledergerber; Michael Messerli; Carlos-A Mestres; Zoran Rancic; Barbara Hasse
Journal:  PLoS One       Date:  2022-08-09       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.